With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...

The state average is calculated by adding total recoveries, arrests, cases registered, etc, under the NDPS Act or in the ...

Patients often wonder why they have to repeat information already in the chart. The answer reveals why AI may become essential to modern medical care.

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

Scottish Government announces its “Preventing Harm, Promoting Recovery” - hoping to turn our European-worst record in drug ...

Incyte (INCY) looks undervalued at 12.5x 2026 EPS, with a pipeline and 4 regulatory catalysts. Click here to read my most ...

S INCE THE third Gulf war began three weeks ago, one number has captured the world’s attention: the price of crude. On March 16th Brent, the global benchmark, briefly topped $10 ...

With marijuana rescheduling still left unfulfilled months after President Donald Trump ordered the process to be completed, ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

However, with Eli Lilly's valuation at around $900 billion today, expectations are also sky-high. That can make it difficult ...

Cancer treatment in India costs 3x more than average ailments. These duty cuts on medicines help reduce out-of-pocket costs in public and private hospitals.